Murine Th1 |
In vitro |
Tcf7 germline KO |
Tcf1 represses IFNγ |
25 |
Murine Th1/Tfh |
LCMV |
Tcf7 long isoforms KO |
Tcf1 required for T memory formation |
9 |
Murine Th17 |
In vitro, EAE |
Tcf7 germline KO |
Tcf1 represses IL17a |
28, 29
|
Murine Th17 |
Colitis, colorectal cancer |
Constitutively active β-catenin |
Tcf1 binds Rorc locus in chromatin accessible regions |
30 |
Murine Thymocytes |
T cell development |
Tcf7 germline KO, constitutively active β-catenin |
Tcf1 promotes thymocyte survival via enhancement of Rorγt |
31 |
Human Th17 |
In vitro |
Wnt inhibitors |
Enhanced Th17 differentiation |
32 |
Human Th17 |
In vitro |
Wnt3a, Wnt5a stimulation |
Reduced Th17 differentiation |
32 |
Murine Tregs |
In vivo T cell development |
Tcf7 hemizygous |
Higher Treg percentage |
44 |
Human and murine Tregs |
In vitro |
None |
Tcf1 interacts with and inhibits Foxp3-mediated transcription |
45 |
Human and murine Tregs |
In vitro |
Gsk3β inhibitor, Wnt3a stimulation |
Reduced Treg suppressive capacity |
45 |
Murine Tregs |
In vivo steady state |
Constitutively active β-catenin |
Spontaneous colitis |
30 |
Murine Tregs |
In vivo steady state |
Treg-specific Tcf1/Lef1 double KO |
Spontaneous multi-organ autoimmunity |
46,47
|